Today's Research Reports on Trending Tickers: Aeterna Zentaris and Intercept Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 28, 2017 / U.S. markets were mixed Monday as retailers surged on strong holiday sales numbers, while chipmakers and oil stocks dragged. The Dow Jones Industrial Average gained 0.10 percent to close at 23,580.78, while the S&P 500 Index declined 0.04 percent to close at 2,604.42. The Nasdaq Composite Index fell 0.15 percent to close at 6,878.52. Online sales on Black Friday totaled a record $5 billion, according to a report from Adobe. Cyber Monday sales are forecasted to be the largest day in online shopping history.

"The (stock) market is looking at the rest of the world and seeing it's a little bit soft, while the early read on holiday sales has been pretty good," said Scott Brown, chief economist at Raymond James in St. Petersburg, Florida, according to Reuters.

RDI Initiates Coverage on:

Aeterna Zentaris Inc. (AEZS)
https://rdinvesting.com/news/?ticker=AEZS

Intercept Pharmaceuticals, Inc. (ICPT)
https://rdinvesting.com/news/?ticker=ICPT

Aeterna Zentaris Inc.'s (AEZS) stock moved 1.90% lower Monday, to close the day at $2.06. The stock recorded a trading volume of 480,247 shares, which was above its three months average volume of 388,826 shares. In the last year, Aeterna Zentaris Inc.'s shares have traded in a range of 0.78 - 4.25. The share price has gained 164.10% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.01 is greater than its 200-day moving average of $1.66. Shares of Aeterna Zentaris have gained roughly 9.57 percent in the past month and are down 42.78 percent year-to-date.

Access RDI's Aeterna Zentaris Inc. Research Report at: https://rdinvesting.com/news/?ticker=AEZS

On Monday, shares in Intercept Pharmaceuticals, Inc. (ICPT) recorded a trading volume of 1,151,695 shares, which was below the three months average volume of 1,663,693 shares. The stock ended the day 6.46% lower at 59.12. The stock is currently trading 56.40% below its 52-week high with a 52-week trading range of 54.98 - 135.59.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $63.66 is below its 200-day moving average of $98.39. Shares of Intercept Pharmaceuticals have fallen roughly 3.76 percent in the past month and are down 45.59 percent year-to-date.

Access RDI's Intercept Pharmaceuticals, Inc. Research Report at: https://rdinvesting.com/news/?ticker=ICPT

Our Actionable Research on Aeterna Zentaris Inc. (AEZS) and Intercept Pharmaceuticals, Inc. (ICPT) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer:

This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:
contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com